News about Global Pharma

OneSource Specialty Pharma Strengthens its Board with Key Independent Directors Appointment

The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others.

Global Pharma | 12/03/2025 | By Aishwarya |  609

Shilpa Medicare Gets SEC-CDSCO Nod for Nor-Ursodeoxycholic Acid Tablets

Shilpa Medicare Ltd. had earlier completed phase-3 clinical studies of this novel product SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets.

Global Pharma | 12/03/2025 | By Aishwarya |  765

Mahajan Imaging & Labs Hosts Roundtable Conference on Integrated Diagnostics and Women Health

The roundtable explored key issues in women’s health, including cancer screening, mental well-being, and the role of integrated diagnostics in early disease detection.

Global Pharma | 12/03/2025 | By Aishwarya |  203

Viking Therapeutics Signs Multi-Year Manufacturing Deal with CordenPharma for Obesity Drug VK2735

Under the terms of the agreement, Viking has secured dedicated capacity for the manufacture of, and a commitment to supply annually, multiple metric tons of VK2735 API.

Global Pharma | 11/03/2025 | By Manvi |  416

Endo to Sale International Pharmaceuticals Business to Knight Therapeutics for USD 99 Million

Endo, Inc. has entered into a definitive agreement to sell its international pharmaceuticals business, primarily operated through Canada-based Paladin Pharma Inc., to Knight Therapeutics Inc. for a total consideration of up to USD 99 million.

Global Pharma | 11/03/2025 | By Manvi |  219

Momentum Biotechnologies Completes Acquisition of OmicScouts

With this transaction, Momentum gains access to a broad portfolio of well-validated proteomic assays that enhance and extend their existing service offerings, enabling clients to seamlessly progress from high-throughput screening into cell-based assays, as well as to discover new targets and biomarkers.

Global Pharma | 11/03/2025 | By Aishwarya |  198

Aragen Strengthens Leadership with Two Key Appointments

Jayadeva joins as the Vice President and Head of Chemical Development Solutions (CDS), one of the largest and critical businesses of Aragen.

Global Pharma | 11/03/2025 | By Aishwarya |  299

Govt of India Invites Proposals for Funding Under PRIP Scheme

The DoP is seeking participation from proprietary firms, partnership firms, limited liability partnerships, startups, and companies or groups of companies registered in India.

Global Pharma | 11/03/2025 | By Aishwarya |  476

Isotopia Launches Isoprotrace in Germany

Isotopia has officially launched Isoprotrace® in Germany. DSD Pharma, a trusted pharmaceutical distributor in Germany, will serve as the exclusive partner for the distribution of Isoprotrace® throughout the country, ensuring efficient, consistent delivery to hospitals, clinics, and diagnostic centres across Germany.

Global Pharma | 10/03/2025 | By Manvi |  136

Indoco's CRO AnaCipher Completed US FDA Inspection

Indoco Remedies Ltd. has announced that its Clinical Research Organisation, AnaCipher, located at Hyderabad, has completed its 5-day comprehensive USFDA inspection. The on-site inspection was conducted from March 3-7, 2025, by investigators from Bioresearch Monitoring Program (BIMO) and Office of Study Integrity & Surveillance (OSIS) of US FDA.

Global Pharma | 10/03/2025 | By Manvi |  327